{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T01:33:55Z","timestamp":1790386435603,"version":"4.1.0"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2021,3,4]],"date-time":"2021-03-04T00:00:00Z","timestamp":1614816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,3,4]],"date-time":"2021-03-04T00:00:00Z","timestamp":1614816000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Leukemia"],"published-print":{"date-parts":[[2021,11]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    In this large single-centre study, we report high prevalence (25%) of, small (&lt;10%) and very small (&lt;1%), paroxysmal nocturnal hemoglobinuria (PNH) clones by high-sensitive cytometry among 3085 patients tested. Given PNH association with bone marrow failures, we analyzed 869 myelodysplastic syndromes (MDS) and 531 aplastic anemia (AA) within the cohort. PNH clones were more frequent and larger in AA vs. MDS (\n                    <jats:italic>p<\/jats:italic>\n                    \u2009=\u20090.04). PNH clone, irrespective of size, was a good predictor of response to immunosuppressive therapy (IST) and to stem cell transplant (HSCT) (in MDS: 84% if PNH+ vs. 44.7% if PNH\u2212,\n                    <jats:italic>p<\/jats:italic>\n                    \u2009=\u20090.01 for IST, and 71% if PNH+ vs. 56.6% if PNH\u2212 for HSCT; in AA: 78 vs. 50% for IST,\n                    <jats:italic>p<\/jats:italic>\n                    \u2009&lt;\u20090.0001, and 97 vs. 77%,\n                    <jats:italic>p<\/jats:italic>\n                    \u2009=\u20090.01 for HSCT). PNH positivity had a favorable impact on disease progression (0.6% vs. 4.9% IPSS-progression in MDS,\n                    <jats:italic>p<\/jats:italic>\n                    \u2009&lt;\u20090.005; and 2.1 vs. 6.9% progression to MDS in AA,\n                    <jats:italic>p<\/jats:italic>\n                    \u2009=\u20090.01), leukemic evolution (6.8 vs. 12.7%,\n                    <jats:italic>p<\/jats:italic>\n                    \u2009=\u20090.01 in MDS), and overall survival [73% (95% CI 68\u201377) vs. 51% (48\u201354),\n                    <jats:italic>p<\/jats:italic>\n                    \u2009&lt;\u20090.0001], with a relative HR for mortality\u00a0of 2.37 (95% CI 1.8\u20133.1;\n                    <jats:italic>p<\/jats:italic>\n                    \u2009&lt;\u20090.0001)\u00a0in\u00a0PNH negative cases, both in univariate and multivariable analysis. Our data suggest systematic PNH testing in AA\/MDS, as it might allow better prediction\/prognostication and consequent clinical\/laboratory follow-up timing.\n                  <\/jats:p>","DOI":"10.1038\/s41375-021-01190-9","type":"journal-article","created":{"date-parts":[[2021,3,4]],"date-time":"2021-03-04T11:03:20Z","timestamp":1614855800000},"page":"3223-3231","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":73,"title":["Clinical and prognostic significance of small paroxysmal nocturnal hemoglobinuria clones in myelodysplastic syndrome and aplastic anemia"],"prefix":"10.1038","volume":"35","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0857-8379","authenticated-orcid":false,"given":"Bruno","family":"Fattizzo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robin","family":"Ireland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan","family":"Dunlop","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah","family":"Yallop","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shireen","family":"Kassam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanna","family":"Large","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shreyans","family":"Gandhi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petra","family":"Muus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles","family":"Manogaran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katy","family":"Sanchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dario","family":"Consonni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wilma","family":"Barcellini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ghulam J.","family":"Mufti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith C. W.","family":"Marsh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3180-3570","authenticated-orcid":false,"given":"Austin G.","family":"Kulasekararaj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,3,4]]},"reference":[{"key":"1190_CR1","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1002\/cytob.21139","volume":"86","author":"A Raza","year":"2014","unstructured":"Raza A, Ravandi F, Rastogi A, Bubis J, Lim SH, Weitz I, et al. A prospective multicenter study of paroxysmal nocturnal hemoglobinuria cells in patients with bone marrow failure. Cytom B Clin Cytom. 2014;86:175\u201382.","journal-title":"Cytom B Clin Cytom."},{"key":"1190_CR2","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1002\/cyto.b.21536","volume":"94B","author":"RE Donohue","year":"2018","unstructured":"Donohue RE, Marcogliese AN, Sasa GS, Elghetany MT, Redkar AA, Bertuch AA, et al. Standardized high\u2010sensitivity flow cytometry testing for paroxysmal nocturnal hemoglobinuria in children with acquired bone marrow failure disorders: a single center US study. Cytom Part B. 2018;94B:699\u2013704.","journal-title":"Cytom Part B"},{"key":"1190_CR3","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1111\/j.0902-4441.2005.t01-1-EJH2467.x","volume":"76","author":"W Wanachiwanawin","year":"2006","unstructured":"Wanachiwanawin W, Siripanyaphinyo U, Piyawattanasakul N, Kinoshita T. A cohort study of the nature of paroxysmal nocturnal hemoglobinuria clones and PIG-A mutations in patients with aplastic anemia. Eur J Hematol. 2006;76:502\u20139.","journal-title":"Eur J Hematol."},{"key":"1190_CR4","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1007\/s00277-014-2267-x","volume":"94","author":"MU Sachdeva","year":"2015","unstructured":"Sachdeva MU, Varma N, Chandra D, Bose P, Malhotra P, Varma S. Multiparameter FLAER-based flow cytometry for screening of paroxysmal nocturnal hemoglobinuria enhances detection rates in patients with aplastic anemia. Ann Hematol. 2015;94:721\u20138.","journal-title":"Ann Hematol"},{"key":"1190_CR5","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1111\/j.1365-2141.2009.07822.x","volume":"147","author":"C Sugimori","year":"2009","unstructured":"Sugimori C, Mochizuki K, Qi Z, Sugimori N, Ishiyama K, Kondo Y, et al. Origin and fate of blood cells deficient in glycosylphosphatidylinositol-anchored protein among patients with bone marrow failure. Br J Haematol. 2009;147:102\u201312.","journal-title":"Br J Haematol."},{"key":"1190_CR6","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1182\/blood-2002-12-3706","volume":"102","author":"K Ishiyama","year":"2003","unstructured":"Ishiyama K, Chuhjo T, Wang H, Yachie A, Omine M, Nakao S. Polyclonal hematopoiesis maintained in patients with bone marrow failure harboring a minor population of paroxysmal nocturnal hemoglobinuria-type cells. Blood. 2003;102:1211\u20136.","journal-title":"Blood."},{"key":"1190_CR7","doi-asserted-by":"publisher","first-page":"1308","DOI":"10.1182\/blood-2005-06-2485","volume":"107","author":"C Sugimori","year":"2006","unstructured":"Sugimori C, Chuhjo T, Feng X, Yamazaki H, Takami A, Teramura M, et al. Minor population of CD55-CD59- blood cells predicts response to immunosuppressive therapy and prognosis in patients with aplastic anemia. Blood. 2006;107:1308\u201314.","journal-title":"Blood."},{"key":"1190_CR8","doi-asserted-by":"publisher","first-page":"3897","DOI":"10.1182\/blood-2002-03-0799","volume":"100","author":"H Wang","year":"2002","unstructured":"Wang H, Chuhjo T, Yasue S, Omine M, Nakao S. Clinical significance of a minor population of paroxysmal nocturnal hemoglobinuria-type cells in bone marrow failure syndrome. Blood. 2002;100:3897\u2013902.","journal-title":"Blood."},{"key":"1190_CR9","doi-asserted-by":"publisher","first-page":"e94","DOI":"10.3324\/haematol.2018.198846","volume":"104","author":"M Griffin","year":"2019","unstructured":"Griffin M, Hillmen P, Munir T, Richards S, Arnold L, Riley K, et al. Significant hemolysis is not required for thrombosis in paroxysmal nocturnal hemoglobinuria. Haematologica. 2019;104:e94\u20136.","journal-title":"Haematologica."},{"key":"1190_CR10","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1002\/cyto.b.20525","volume":"78","author":"MJ Borowitz","year":"2010","unstructured":"Borowitz MJ, Craig FE, Digiuseppe JA, Illingworth AJ, Rosse W, Sutherland DR, et al. Guidelines for the diagnosis and monitoring of paroxysmal nocturnal hemoglobinuria and related disorders by flow cytometry. Cytom B Clin Cytom. 2010;78:211\u201330.","journal-title":"Cytom B Clin Cytom."},{"key":"1190_CR11","doi-asserted-by":"crossref","unstructured":"Donohue RE, Marcogliese AN, Sasa GS. Standardized high-sensitivity flow cytometry testing for paroxysmal nocturnal hemoglobinuria in children with acquired bone marrow failure disorders: a single center US study. Cytometry B Clin Cytom. 2018;94:699\u2013704.","DOI":"10.1002\/cyto.b.21536"},{"key":"1190_CR12","unstructured":"Stata-Corp. Stata: Release 13. Statistical Software. College Station, TX: StataCorp LP; 2013."},{"key":"1190_CR13","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1111\/bjh.16427","volume":"189","author":"SJ Richards","year":"2020","unstructured":"Richards SJ, Dickinson AJ, Cullen MJ, Griffin M, Munir T, McKinley C, et al. Presentation clinical, haematological and immunophenotypic features of 1081 patients with GPI-deficient (paroxysmal nocturnal haemoglobinuria) cells detected by flow cytometry. Br J Haematol. 2020;189:954\u201366.","journal-title":"Br J Haematol."},{"key":"1190_CR14","first-page":"107","volume":"7","author":"YS Fraiman","year":"2016","unstructured":"Fraiman YS, Cuka N, Batista D, Vuica-Ross M, Moliterno AR. Development of paroxysmal nocturnal hemoglobinuria in CALR-positive myeloproliferative neoplasm. J Blood Med. 2016;7:107\u201310.","journal-title":"J Blood Med."},{"key":"1190_CR15","doi-asserted-by":"publisher","first-page":"96","DOI":"10.5858\/2005-129-96-ALLTIA","volume":"129","author":"SP Shaheen 2nd","year":"2005","unstructured":"Shaheen SP 2nd, Talwalkar SS, Simons R, Yam L. Acute lymphoblastic leukemic transformation in a patient with chronic idiopathic myelofibrosis and paroxysmal nocturnal hemoglobinuria: a case report and review of the literature. Arch Pathol Lab Med. 2005;129:96\u20139.","journal-title":"Arch Pathol Lab Med."},{"key":"1190_CR16","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1111\/bjh.12661","volume":"164","author":"A Kulagin","year":"2014","unstructured":"Kulagin A, Lisukov I, Ivanova M, Golubovskaya I, Kruchkova I, Bondarenko S, et al. Prognostic value of paroxysmal nocturnal haemoglobinuria clone presence in aplastic anaemia patients treated with combined immunosuppression: results of two-centre prospective study. Br J Haematol. 2014;164:546\u201354.","journal-title":"Br J Haematol."},{"key":"1190_CR17","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1007\/s00277-015-2348-5","volume":"94","author":"X Zhao","year":"2015","unstructured":"Zhao X, Zhang L, Jing L, Zhou K, Li Y, Peng G, et al. The role of paroxysmal nocturnal hemoglobinuria clones in response to immunosuppressive therapy of patients with severe aplastic anemia. Ann Hematol. 2015;94:1105\u201310.","journal-title":"Ann Hematol"},{"key":"1190_CR18","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1111\/j.1365-2141.2008.07450.x","volume":"144","author":"P Scheinberg","year":"2009","unstructured":"Scheinberg P, Wu CO, Nunez O, Young NS. Predicting response to immunosuppressive therapy and survival in severe aplastic anaemia. Br J Haematol. 2009;144:206\u201316.","journal-title":"Br J Haematol"},{"key":"1190_CR19","doi-asserted-by":"publisher","first-page":"1765","DOI":"10.1182\/bloodadvances.2018019414","volume":"2","author":"M Stahl","year":"2018","unstructured":"Stahl M, DeVeaux M, de Witte T, Neukirchen J, Sekeres MA, Brunner AM, et al. The use of immunosuppressive therapy in MDS: clinical outcomes and their predictors in a large international patient cohort. Blood Adv. 2018;2:1765\u201372.","journal-title":"Blood Adv"},{"key":"1190_CR20","doi-asserted-by":"crossref","unstructured":"Luzzatto L. Recent advances in the pathogenesis and treatment of paroxysmal nocturnal hemoglobinuria. F1000Res. 2016;5:F1000 Faculty Rev-209.","DOI":"10.12688\/f1000research.7288.1"},{"key":"1190_CR21","doi-asserted-by":"publisher","first-page":"587","DOI":"10.3389\/fonc.2018.00587","volume":"8","author":"M Medinger","year":"2018","unstructured":"Medinger M, Drexler B, Lengerke C, Passweg J. Pathogenesis of acquired aplastic anemia and the role of the bone marrow microenvironment. Front Oncol. 2018;8:587.","journal-title":"Front Oncol."},{"key":"1190_CR22","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1080\/17474086.2017.1339597","volume":"10","author":"W Barcellini","year":"2017","unstructured":"Barcellini W. The relationship between idiopathic cytopenias\/dysplasias of uncertain significance (ICUS\/IDUS) and autoimmunity. Expert Rev Hematol. 2017;10:649\u201357.","journal-title":"Expert Rev Hematol."}],"container-title":["Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41375-021-01190-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41375-021-01190-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41375-021-01190-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,22]],"date-time":"2023-10-22T07:30:22Z","timestamp":1697959822000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41375-021-01190-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,4]]},"references-count":22,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2021,11]]}},"alternative-id":["1190"],"URL":"https:\/\/doi.org\/10.1038\/s41375-021-01190-9","relation":{},"ISSN":["0887-6924","1476-5551"],"issn-type":[{"value":"0887-6924","type":"print"},{"value":"1476-5551","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,4]]},"assertion":[{"value":"15 February 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 January 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 February 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 March 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}